The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Jolene Van Alstine, ...
This article originally appeared on Politifact. What does it mean when a warning label is removed from a medication after two decades? But the science wasn’t so clear cut. The study that drove the ...
Here's how the therapy containing estrogen and progesterone initially got a bad rap—and what the research says about its potential benefits. Though a 2002 study led many to believe that hormone ...
Researchers uncovered how estrogen subtly reshapes learning by strengthening dopamine reward signals in the brain. Rats learned faster when estrogen levels were high and struggled when the hormone’s ...
Genevieve Hofmann has participated in advisory boards with Astellis Pharma and Mayne Pharma. She is President-elect of the Board of Directors of National Association of Nurse Practitioner's in Women ...
On Monday, US Health and Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Dr. Marty Makary announced that after 20 years, they were righting a medical ...
Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...
The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient. By Roni Caryn ...
Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...
In a pivotal move, the US Food and Drug Administration said Monday that it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms, a ...
COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal ...
New research has demonstrated that a combined regimen of growth hormone and testosterone is safe, well-tolerated, and is associated with meaningful improvements in muscle mass, strength, and mobility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback